ABCC1 and neoplasm: In tumor cells, the 190 kDa MRP1 protein can confer resistance to a large number of antineoplastic drugs, including anthraciclines, such as doxorubicin and daunorubicin, vinca alkaloids, such as vincristine, and other drugs, including etoposide and methotrexate (MTX) [6].